Athanor Capital, LP - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 176 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
Athanor Capital, LP ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$624,000
-32.9%
24,398
-42.2%
0.01%
-33.3%
Q4 2020$930,000
+13.6%
42,197
-7.3%
0.02%
-32.3%
Q3 2020$819,000
+309.5%
45,501
+477.3%
0.03%
+210.0%
Q2 2020$200,000
-62.7%
7,882
-67.6%
0.01%
-58.3%
Q4 2019$536,000
+130.0%
24,350
+64.5%
0.02%
-20.0%
Q2 2019$233,00014,8000.03%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders